Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis - Wikidata - awgldk - TriplyDB

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

http://www.wikidata.org/entity/Q30434677

about

Biomarkers in vasculitis Biomarkers in nephrology: Core Curriculum 2013 Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.Combining capillary electrophoresis matrix-assisted laser desorption/ionization mass spectrometry and stable isotopic labeling techniques for comparative crustacean peptidomics.Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria Deciphering the peptidome of urine from ovarian cancer patients and healthy controls.Addressing the challenge of defining valid proteomic biomarkers and classifiers.Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Data driven linear algebraic methods for analysis of molecular pathways: application to disease progression in shock/trauma.Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population.Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.CKD273, a new proteomics classifier assessing CKD and its prognosis Collagen peptides in urine: a new promising biomarker for the detection of colorectal liver metastases Clinical proteomics identifies urinary CD14 as a potential biomarker for diagnosis of stable coronary artery disease Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis.Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease.Implementation of proteomic biomarkers: making it work.Prediction of acute coronary syndromes by urinary proteome analysis.Urinary proteomics for early diagnosis in diabetic nephropathy.Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction.Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups.Improved prognostic diagnosis of systemic lupus erythematosus in an early stage of disease by a combination of different predictive biomarkers identified by proteome analysis.CE-MS in biomarker discovery, validation, and clinical application.Clinical application of urinary proteomics/peptidomics.Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Proteomic biomarkers in kidney disease: issues in development and implementation.Body fluid peptide and protein signatures in diabetic kidney diseases.Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.The long path towards implementation of clinical proteomics: Exemplified based on CKD273.Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

P2860

Q26825345-F1D3E254-491E-441D-80C9-043CA67650CF Q26861451-5C79F2B1-7E4E-4AE7-B9D1-F46333CBDDBC Q27305109-FF4A739E-72A1-4448-9B82-386D269C1DD9 Q28477629-4BDC944A-B30F-4816-B97C-2D1C273A1415 Q28478586-7D5AFD32-FA36-4FAC-B0B6-9D3CA17973E4 Q28484968-5E3D88F4-2AD3-4F3C-AE93-EE4D11656D2D Q28748796-9D5AD2E4-46F6-4484-96EB-B5C1AA3C49E4 Q30430034-F8555A68-0497-4621-808B-23D7B88EED5F Q33545497-559C42D8-ED66-4C8A-B015-E58512C62EDB Q33591146-1931D392-9D86-45FE-BA81-DF5F3B16BD50 Q33735287-1D7CCD14-1CB7-4AFE-B207-078301C09194 Q33786098-BC2DC2D6-E9DC-4102-8C09-9D2008D8230E Q33786157-3BF37FA8-429E-4BC7-956B-10E339EBD7B4 Q33985444-8721B8F5-E171-4835-84DE-E9C32C84965F Q34112355-CCBD78C2-B256-442D-8BEB-03AB55E564A9 Q34140378-8D611826-F3C6-4992-ADF9-9FAAE41FE675 Q34725022-0812438D-4425-417C-8D0F-75AB654DFB53 Q34729912-27E61913-D8D4-468E-9B4B-E319E03E61BE Q34970404-828FB2EE-7348-4A2B-9043-3B29C0E4A5B1 Q35558889-167CF560-59F5-4D28-A896-6D3C40F94E09 Q35767318-C2ACBD75-F10E-4B3F-98DF-E9481EC16205 Q35903097-F1BAEFD7-192B-4212-B8BE-6C13D30D799C Q36053833-8F1EEE4D-6023-4FF1-BE1E-9A73F9A0720C Q36214366-8ABAB143-96DF-4EA4-8D07-86F098C2EE30 Q36297774-591137D1-94B1-419D-8E92-6C505AFCF808 Q36300622-BBF15711-F426-4228-B6A1-3FA7875F5857 Q36410737-E7971080-E7D4-48BC-9AAF-3C57AED9F2DB Q36878725-563AFC34-364E-46E3-8C6C-A49A334B7A8E Q36993564-97537057-D083-41F5-905B-ADEADECB4C55 Q37657244-CF49576A-4D6A-4FBA-A23F-B25609492FE7 Q37720667-8A2BAD8D-068E-47A1-A105-1A8235306483 Q37833587-33FA266F-EC6F-4C74-8489-1C1FFF4616E9 Q37945790-CC759B0B-9B0D-444D-8012-280B167E91DC Q38222628-763E8B6E-B3D9-4A44-B930-BAD58259FF7C Q38340351-21BB95A2-2CD6-4205-9D0F-9DDEA80A10A7 Q38341211-8620044F-596C-42C6-B227-FC2EA58E3D48 Q38553924-1082F07C-BF9B-4C46-AD2C-967BB3984864 Q38906256-04C67717-7F2A-48CA-B90F-A4EDC2032C93 Q39055330-72BF118F-89B0-4819-BC38-58A2AF524995 Q39094572-FCA9862E-45D7-4870-B76B-14E4675AFFEF

P2860

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

http://www.wikidata.org/entity/Q30434677

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification and validation ...... antibody-associated vasculitis

@ast

Identification and validation ...... antibody-associated vasculitis

@en

type

label

Identification and validation ...... antibody-associated vasculitis

@ast

Identification and validation ...... antibody-associated vasculitis

@en

prefLabel

Identification and validation ...... antibody-associated vasculitis

@ast

Identification and validation ...... antibody-associated vasculitis

@en

P1433

Q30434677-C2ADA4AA-DE71-4A22-8735-10C6F40631FF

P1476

Q30434677-4FA31E05-7C92-4D0A-BEAB-15B84805CE41

P2093

Q30434677-1A5B3344-8FF9-4934-AA0D-CBE8C495DEF9

Q30434677-4801FE30-8501-4AF6-8CE0-4DD994B42C9D

Q30434677-535386F0-BF32-4380-8403-06DEC4338FB7

Q30434677-59A7153C-2F33-46D6-9BEA-7E0FBAAD65E2

Q30434677-AD27C3A8-4428-42AF-A537-C8A2C3B56ED9

Q30434677-B26DBE4C-731B-4DAB-8612-5906F94D388C

Q30434677-B26F3148-36A6-408F-BE3B-E3DFB0B407D1

P2860

Q30434677-0756AC81-AEB8-4B07-9CAD-239D4195331F

Q30434677-16880AB0-E290-47FF-8F7C-6491D2F618A2

Q30434677-1698AE4F-4198-429F-8396-AB79DE5B62F3

Q30434677-1950B14C-C036-40E8-A50E-5F8DFF86A8BF

Q30434677-1B9AE4E0-D08F-4AF7-974D-55432571AB15

Q30434677-1F491771-A93E-482C-8FD7-6D8723339B17

Q30434677-1FD06D5A-0E4A-444C-B676-946210A9633B

Q30434677-2CCB8D59-6407-4CA3-897A-04E32AD2CB37

Q30434677-58CEA74A-8030-4625-8610-809B5DE1B551

Q30434677-5ABFD8E9-5F69-4BE2-867D-E809D83C329F

P304

Q30434677-711B6C7D-CA49-46DC-946E-B47A4ED84844

P31

Q30434677-B423B3FE-F6F7-43BB-9B25-190D2729BF68

P356

Q30434677-4C4F8EF5-8BFE-42C0-954A-AEF8846848DF

P433

Q30434677-B893727B-36CF-495C-AC1A-78DEF104A555

P478

Q30434677-7892E3CA-9ABC-4A8B-A41A-49C5A38043C8

P50

Q30434677-61195066-1FE6-4BE7-B8CF-D77B5E778883

Q30434677-633811EA-1A2D-45E2-82EE-CF22EF0F6233

P577

Q30434677-B4B299DD-F388-4F68-958A-0575BB3C6F41

P698

Q30434677-F08913E2-E226-47CD-9AC7-59D673A50958

P921

Q30434677-0D82FC5E-80E8-40FF-966C-FCE96EA11EC5

Q30434677-7D2B7D06-64B5-4AA1-979B-431F29083FBE

P932

Q30434677-7B5F2AC1-64FE-45DD-A522-E292970B955E

P356

MCP.M800529-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Identification and validation ...... antibody-associated vasculitis

@en

P2093

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

David M Good

http://www.w3.org/2001/XMLSchema#string

Harald Mischak

http://www.w3.org/2001/XMLSchema#string

Harald Rupprecht

http://www.w3.org/2001/XMLSchema#string

Joshua J Coon

http://www.w3.org/2001/XMLSchema#string

Marion Haubitz

http://www.w3.org/2001/XMLSchema#string

Mohammed Dakna

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

The current status of neutrophil cytoplasmic antibodies

Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase

Performance characteristics of electron transfer dissociation mass spectrometry

Endothelial tissue factor stimulation by proteinase 3 and elastase

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Electron transfer dissociation of peptide anions.

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

P304

2296-2307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M800529-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Woywodt

P577

2009-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19564150

http://www.w3.org/2001/XMLSchema#string

P921

P932

2758757

http://www.w3.org/2001/XMLSchema#string